Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Madharry who wrote (901)	1/21/2002 5:06:18 PM
From: Icebrg	Read Replies (1) of 3044

Madharry I think this acquisition should be looked upon from Millennium's stated aspiration of becoming "The Biopharmaceutical of the Future". One might or might not approve of such goals. If one doesn't - one shouldn't hold the stock in the first place. Millennium is very well aware of the fact that they will not be able to fullfil their ambition, if they do not have a strong presence in the cardiac market segments. Therefore one should IMHO not look upon this transaction searching for immediate synergies, but look upon it as something of a shortcut to the required much stronger presence in the cardiac arena. MLNM has, as far as I have understood some very interesting early leads in this slot, and the access to Cor's expertise should help a lot in their future development work. Apart from everything else. I (somewhat naively perhaps) don't look for the dollars and cents rationale behind this transaction, but rather consider it to be a necessary step on the way to build the type of company they are aiming for. Ice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next